(Total Views: 538)
Posted On: 04/02/2019 8:40:40 AM
Post# of 54

$CBIO News Article - Catalyst Biosciences Initiates a Phase 2b Trial of Dalcinonacog Alfa for the Treatment of Hemophilia B https://marketwirenews.com/news-releases/cata...31776.html


My Twitter: WhyteStocks